nach oben

European Archives of Oto-Rhino-Laryngology

Erschienen in:

01.02.2011 | Review Article

Effects of tumour stage, comorbidity and therapy on survival of laryngeal cancer patients: a systematic review and a meta-analysis

verfasst von: Elisabeth Rudolph, Gerhard Dyckhoff, Heiko Becher, Andreas Dietz, Heribert Ramroth

Erschienen in: European Archives of Oto-Rhino-Laryngology | Ausgabe 2/2011

Einloggen, um Zugang zu erhalten

Abstract

Laryngeal cancer is the second most common cancer of the respiratory tract with a relative 5-year survival over all tumour sites in the USA (61.6%; SEER 2009), which is much better than other head and neck cancers. The aim of this paper is to review and summarise data on the survival of laryngeal cancer patients. Literature search was conducted to identify articles in PubMed up to June 2009. Thirty studies with different study aims including sufficient information on survival of laryngeal cancer patients were identified. The 5-year overall survival ranged from 0 to 100%, depending on the T- and N-category, therapeutic approach and tumour location. The involvement of other factors such as genetics, nutrition and lifestyle habits remains uncertain. Our meta-analysis on a subgroup of published studies yielded an overall 5-year relative survival rate of 64.2% (95% confidence interval 63.7–64.7%). Different study aims and patient selection criteria prohibit general conclusions. However, this review may provide an actual picture of the complexity of factors influencing the survival of laryngeal cancer patients.

Ferlay J, Bray F, Pisani P, Parkin D (2001) GLOBOCAN 2000: cancer incidence, mortality and prevalence worldwide. IARC cancer base no. 5, IARC, Lyon, version 1.0

Ramroth H, Dietz A, Becher H (2004) Interaction effects and population-attributable risks for smoking and alcohol on laryngeal cancer and its subsites. A case–control study from Germany. Methods Inf Med 43:499–504. doi:10.1267/METH04050499 PubMed

Shangina O, Brennan P, Szeszenia-Dabrowska N, Mates D, Fabiánová E, Fletcher T et al (2006) Occupational exposure and laryngeal and hypopharyngeal cancer risk in central and eastern Europe. Am J Epidemiol 164:367–375. doi:10.1093/aje/kwj208 CrossRefPubMed

Talamini R, Bosetti C, Vecchia CL, Maso LD, Levi F, Bidoli E et al (2002) Combined effect of tobacco and alcohol on laryngeal cancer risk: a case–control study. Cancer Causes Control 13:957–964CrossRefPubMed

Hashibe M, Boffetta P, Zaridze D, Shangina O, Szeszenia-Dabrowska N, Mates D et al (2007) Contribution of tobacco and alcohol to the high rates of squamous cell carcinoma of the supraglottis and glottis in Central Europe. Am J Epidemiol 165:814–820. doi:10.1093/aje/kwk066 CrossRefPubMed

IARC (2003) Monographs on the evaluation of carcinogenic risks to humans tobacco smoke and involuntary smoking. IARC, Lyon, p 83

Ramroth H, Dietz A, Becher H (2008) Environmental tobacco smoke and laryngeal cancer: results from a population-based case–control study. Eur Arch Otorhinolaryngol 265:1367–1371. doi:10.1007/s00405-008-0651-7 CrossRefPubMed

Lee YCA, Boffetta P, Sturgis EM, Wei Q, Zhang ZF, Muscat J et al (2008) Involuntary smoking and head and neck cancer risk: pooled analysis in the international head and neck cancer epidemiology consortium. Cancer Epidemiol Biomarkers Prev 17:1974–1981. doi:10.1158/1055-9965.EPI-08-0047 CrossRefPubMed

Becher H, Ramroth H, Ahrens W, Risch A, Schmezer P, Dietz A (2005) Occupation, exposure to polycyclic aromatic hydrocarbons and laryngeal cancer risk. Int J Cancer 116:451–457. doi:10.1002/ijc.21049 CrossRefPubMed

10.

Ramroth H, Dietz A, Ahrens W, Becher H (2008) Occupational wood dust exposure and the risk of laryngeal cancer: a population based case–control study in Germany. Am J Ind Med 51:648–655. doi:10.1002/ajim.20605 CrossRefPubMed

11.

Boffetta P, Richiardi L, Berrino F, Estève J, Pisani P, Crosignani P et al (2003) Occupation and larynx and hypopharynx cancer: an international case–control study in France, Italy, Spain, and Switzerland. Cancer Causes Control 14:203–212CrossRefPubMed

12.

Dietz A, Ramroth H, Urban T, Ahrens W, Becher H (2004) Exposure to cement dust, related occupational groups and laryngeal cancer risk: results of a population based case–control study. Int J Cancer 108:907–911. doi:10.1002/ijc.11658 CrossRefPubMed

13.

http://seer.cancer.gov/csr/1975_2006/results_merged/topic_survival.pdf

14.

Sant M, Allemani C, Santaquilani M, Knijn A, Marchesi F, Capocaccia R et al (2009) EUROCARE-4. Survival of cancer patients diagnosed in 1995–1999. Results and commentary. Eur J Cancer 45:931–991. doi:10.1016/j.ejca.2008.11.018 CrossRefPubMed

15.

Pfister DG, Laurie SA, Weinstein GS, Mendenhall WM, Adelstein DJ et al (2006) American society of clinical oncology clinical practice guideline for the use of larynx-preservation strategies in the treatment of laryngeal cancer. J Clin Oncol 24:3693–3704. doi:10.1200/JCO.2006.07.4559 CrossRefPubMed

16.

Holsinger FC, Weber RS (2007) Swing of the surgical pendulum: a return to surgery for treatment of head and neck cancer in the 21st century? Int J Radiat Oncol Biol Phys 69:S129–S131. doi:10.1016/j.ijrobp.2007.05.044 PubMed

17.

Boscolo-Rizzo P, Maronato F, Marchiori C, Gava A, Mosto MCD (2008) Long-term quality of life after total laryngectomy and postoperative radiotherapy versus concurrent chemoradiotherapy for laryngeal preservation. Laryngoscope 118:300–306. doi:10.1097/MLG.0b013e31815a9ed3 CrossRefPubMed

18.

Chen AY, Matson LK, Roberts D, Goepfert H (2001) The significance of comorbidity in advanced laryngeal cancer. Head Neck 23:566–572CrossRefPubMed

19.

Piccirillo JF, Lacy PD, Basu A, Spitznagel EL (2002) Development of a new head and neck cancer-specific comorbidity index. Arch Otolaryngol Head Neck Surg 128:1172–1179PubMed

20.

Sabin SL, Rosenfeld RM, Sundaram K, Har-el G, Lucente FE (1999) The impact of comorbidity and age on survival with laryngeal cancer. Ear Nose Throat J 78:578, 581–578, 584

21.

Castro MAF, Dedivitis RA, Ribeiro KCB (2007) Comorbidity measurement in patients with laryngeal squamous cell carcinoma. ORL J Otorhinolaryngol Relat Spec 69:146–152. doi:10.1159/000099223 PubMed

22.

Dietz A, Boehm A, Mozet C, Wichmann G, Giannis A (2008) Current aspects of targeted therapy in head and neck tumors. Eur Arch Otorhinolaryngol 265(Suppl 1):S3–S12. doi:10.1007/s00405-008-0697-6 CrossRefPubMed

23.

Machtay M, Moughan J, Trotti A, Garden AS, Weber RS, Cooper JS et al (2008) Factors associated with severe late toxicity after concurrent chemoradiation for locally advanced head and neck cancer: an RTOG analysis. J Clin Oncol 26:3582–3589. doi:10.1200/JCO.2007.14.8841 CrossRefPubMed

24.

Pointreau Y, Garaud P, Chapet S, Sire C, Tuchais C, Tortochaux J et al (2009) Randomized trial of induction chemotherapy with cisplatin and 5-fluorouracil with or without docetaxel for larynx preservation. J Natl Cancer Inst 101:498–506. doi:10.1093/jnci/djp007 CrossRefPubMed

25.

Lefebvre JL, Ang KK, Panel LPC (2009) Larynx preservation clinical trial design: key issues and recommendations—a consensus panel summary. Int J Radiat Oncol Biol Phys 73:1293–1303CrossRefPubMed

26.

Dietz A, Boehm A, Horn IS, Kruber P, Bechmann I, Golusinski W et al (2010) Assay-based response evaluation in head and neck oncology: requirements for better decision making. Eur Arch Otorhinolaryngol 267:483–494. doi:10.1007/s00405-009-1191-5 CrossRefPubMed

27.

Wittekind C, Sobin L (2002) TNM classification of malignant tumours. Wiley-Liss, New York

28.

Molina MA, Cheung MC, Perez EA, Byrne MM, Franceschi D, Moffat FL et al (2008) African American and poor patients have a dramatically worse prognosis for head and neck cancer: an examination of 20,915 patients. Cancer 113:2797–2806. doi:10.1002/cncr.23889 CrossRefPubMed

29.

Sutton A, Abrams K, Jones D, Sheldon T, Song F (2000) Methods for meta-analysis in medical research. Wiley, Chichester

30.

Cantor AB (2001) Projecting the standard error of the Kaplan–Meier estimator. Stat Med 20:2091–2097. doi:10.1002/sim.856 CrossRefPubMed

31.

Dikshit RP, Boffetta P, Bouchardy C, Merletti F, Crosignani P, Cuchi T et al (2005) Lifestyle habits as prognostic factors in survival of laryngeal and hypopharyngeal cancer: a multicentric European study. Int J Cancer 117:992–995. doi:10.1002/ijc.21244 CrossRefPubMed

32.

Fakhry C, Westra WH, Li S, Cmelak A, Ridge JA, Pinto H et al (2008) Improved survival of patients with human papillomavirus-positive head and neck squamous cell carcinoma in a prospective clinical trial. J Natl Cancer Inst 100:261–269. doi:10.1093/jnci/djn011 CrossRefPubMed

33.

Adamopoulos G, Yotakis I, Apostolopoulos K, Manolopoulos L, Kandiloros D, Ferekidis E (1997) Supraglottic laryngectomy-series report and analysis of results. J Laryngol Otol 111:730–734CrossRefPubMed

34.

Hoffman HT, Porter K, Karnell LH, Cooper JS, Weber RS, Langer CJ et al (2006) Laryngeal cancer in the United States: changes in demographics, patterns of care, and survival. Laryngoscope 116:1–13. doi:10.1097/01.mlg.0000236095.97947.26 CrossRefPubMed

35.

Rachet B, Quinn MJ, Cooper N, Coleman MP (2008) Survival from cancer of the larynx in England and Wales up to 2001. Br J Cancer 99(Suppl 1):S35–S37. doi:10.1038/sj.bjc.6604581 CrossRefPubMed

36.

Raitiola H, Pukander J, Laippala P (1999) Glottic and supraglottic laryngeal carcinoma: differences in epidemiology, clinical characteristics and prognosis. Acta Otolaryngol 119:847–851CrossRefPubMed

37.

LaRosa F, Petrinelli AM, Stracci F, Ammetto C, Casucci P, Mastrandrea V (2000) Long term survival of upper aerodigestive tract cancer in male patients in the Umbria region (Italy). Eur J Epidemiol 16:489–494CrossRef

38.

Tamura Y, Tanaka S, Asato R, Hirano S, Yamashita M, Tamaki H, et al. (2007) Therapeutic outcomes of laryngeal cancer at Kyoto University Hospital for 10 years. Acta Otolaryngol Suppl, pp 62–65. doi:10.1080/00016480601067990

39.

DiMartino E, Sellhaus B, Hausmann R, Minkenberg R, Lohmann M, Esthofen MW (2002) Survival in second primary malignancies of patients with head and neck cancer. J Laryngol Otol 116:831–838. doi:10.1258/00222150260293664 CrossRef

40.

Olthoff A, Ewen A, Wolff H, Hermann R, Vorwerk H, Hille A et al (2009) Organ function and quality of life after transoral laser microsurgery and adjuvant radiotherapy for locally advanced laryngeal cancer. Strahlenther Onkol 185:303–309. doi:10.1007/s00066-009-1967-y CrossRefPubMed

41.

Fung K, Lyden TH, Lee J, Urba SG, Worden F, Eisbruch A et al (2005) Voice and swallowing outcomes of an organ-preservation trial for advanced laryngeal cancer. Int J Radiat Oncol Biol Phys 63:1395–1399. doi:10.1016/j.ijrobp.2005.05.004 CrossRefPubMed

42.

Preuss SF, Cramer K, Klussmann JP, Eckel HE, Guntinas-Lichius O (2009) Transoral laser surgery for laryngeal cancer: outcome, complications and prognostic factors in 275 patients. Eur J Surg Oncol 35:235–240. doi:10.1016/j.ejso.2008.01.012 PubMed

43.

Cabanillas R, Rodrigo JP, Llorente JL, Suárez C (2008) Oncologic outcomes of transoral laser surgery of supraglottic carcinoma compared with a transcervical approach. Head Neck 30:750–755. doi:10.1002/hed.20778 CrossRefPubMed

44.

Motta S, Moscillo L, Imperiali M, Motta G (2003) CO2 laser treatment of bilateral vocal cord paralysis in adduction. ORL J Otorhinolaryngol Relat Spec 65:359–365. doi:10.1159/000076055 PubMed

45.

Hartl DM, de Monès E, Hans S, Janot F, Brasnu D (2007) Treatment of early-stage glottic cancer by transoral laser resection. Ann Otol Rhinol Laryngol 116:832–836PubMed

46.

Ansarin M, Santoro L, Cattaneo A, Massaro MA, Calabrese L, Giugliano G et al (2009) Laser surgery for early glottic cancer: impact of margin status on local control and organ preservation. Arch Otolaryngol Head Neck Surg 135:385–390. doi:10.1001/archoto.2009.10 CrossRefPubMed

47.

Hinni ML, Salassa JR, Grant DG, Pearson BW, Hayden RE, Martin A et al (2007) Transoral laser microsurgery for advanced laryngeal cancer. Arch Otolaryngol Head Neck Surg 133:1198–1204. doi:10.1001/archotol.133.12.1198 CrossRefPubMed

48.

Prades JM, Simon PG, Timoshenko AP, Dumollard JM, Schmitt T, Martin C (2005) Extended and standard supraglottic laryngectomies: a review of 110 patients. Eur Arch Otorhinolaryngol 262:947–952. doi:10.1007/s00405-004-0882-1 CrossRefPubMed

49.

Pellini R, Pichi B, Ruscito P, Ceroni AR, Caliceti U, Rizzotto G et al (2008) Supracricoid partial laryngectomies after radiation failure: a multi-institutional series. Head Neck 30:372–379. doi:10.1002/hed.20709 CrossRefPubMed

50.

Piazza C, Peretti G, Cattaneo A, Garrubba F, Zinis LORD, Nicolai P (2007) Salvage surgery after radiotherapy for laryngeal cancer: from endoscopic resections to open-neck partial and total laryngectomies. Arch Otolaryngol Head Neck Surg 133:1037–1043. doi:10.1001/archotol.133.10.1037 CrossRefPubMed

51.

Santos CR, Kowalski LP, Magrin J, Fogaroli RC, Santos JC, Sabóia MV et al (1998) Prognostic factors in supraglottic carcinoma patients treated by surgery or radiotherapy. Ann Otol Rhinol Laryngol 107:697–702PubMed

52.

Sevilla MA, Rodrigo JP, Llorente JL, Cabanillas R, López F, Suárez C (2008) Supraglottic laryngectomy: analysis of 267 cases. Eur Arch Otorhinolaryngol 265:11–16. doi:10.1007/s00405-007-0415-9 CrossRefPubMed

53.

Mendenhall WM, Amdur RJ, Morris CG, Hinerman RW (2001) T1–T2N0 squamous cell carcinoma of the glottic larynx treated with radiation therapy. J Clin Oncol 19:4029–4036PubMed

54.

Reddy SP, Hong RL, Nagda S, Emami B (2007) Effect of tumor bulk on local control and survival of patients with T1 glottic cancer: a 30-year experience. Int J Radiat Oncol Biol Phys 69:1389–1394. doi:10.1016/j.ijrobp.2007.05.077 CrossRefPubMed

55.

Kao J, Lavaf A, Teng MS, Huang D, Genden EM (2008) Adjuvant radiotherapy and survival for patients with node-positive head and neck cancer: an analysis by primary site and nodal stage. Int J Radiat Oncol Biol Phys 71:362–370. doi:10.1016/j.ijrobp.2007.09.058 CrossRefPubMed

56.

Rusthoven KE, Raben D, Chen C (2008) Improved survival in patients with stage III–IV head and neck cancer treated with radiotherapy as primary local treatment modality. Int J Radiat Oncol Biol Phys 72:343–350. doi:10.1016/j.ijrobp.2007.12.046 CrossRefPubMed

57.

Nguyen-Tan PF, Le QT, Quivey JM, Singer M, Terris DJ, Goffinet DR et al (2001) Treatment results and prognostic factors of advanced T3–4 laryngeal carcinoma: the University of California, San Francisco (UCSF) and Stanford University Hospital (SUH) experience. Int J Radiat Oncol Biol Phys 50:1172–1180CrossRefPubMed

58.

Spector JG, Sessions DG, Lenox J, Simpson J (2006) Management of T3N1 glottic carcinoma: therapeutic outcomes. Laryngoscope 116:106–110. doi:10.1097/01.mlg.0000184767.62682.3d CrossRefPubMed

59.

MacKenzie RG, Franssen E, Balogh JM, Gilbert RW, Birt D, Davidson J (2000) Comparing treatment outcomes of radiotherapy and surgery in locally advanced carcinoma of the larynx: a comparison limited to patients eligible for surgery. Int J Radiat Oncol Biol Phys 47:65–71CrossRefPubMed

60.

Herchenhorn D, Dias FL, Ferreira CG, Araújo CM, Lima RA, Small IA et al (2008) Impact of previous tracheotomy as a prognostic factor in patients with locally advanced squamous cell carcinoma of the larynx submitted to concomitant chemotherapy and radiation. ORL J Otorhinolaryngol Relat Spec 70:381–388. doi:10.1159/000163034 PubMed

61.

Johnson J (2006) Outcomes in laryngeal cancer: a product of the learning curve? Laryngoscope 116:1529. doi:10.1097/01.mlg.0000236092.52123.a9 CrossRefPubMed

62.

Bernier J, Domenge C, Ozsahin M, Matuszewska K, Lefèbvre JL, Greiner RH et al (2004) Postoperative irradiation with or without concomitant chemotherapy for locally advanced head and neck cancer. N Engl J Med 350:1945–1952CrossRefPubMed

63.

Cooper JS, Pajak TF, Forastiere AA, Jacobs J, Campbell BH, Saxman SB et al (2004) Postoperative concurrent radiotherapy and chemotherapy for high-risk squamous-cell carcinoma of the head and neck. N Engl J Med 350:1937–1944CrossRefPubMed

64.

Lefebvre JL, Chevalier D, Luboinski B, Kirkpatrick A, Collette L, Sahmoud T (1996) Larynx preservation in pyriform sinus cancer: preliminary results of a European organization for research and treatment of cancer phase III trial. EORTC head and neck cancer cooperative group. J Natl Cancer Inst 88:890–899CrossRefPubMed

65.

The Department of Veterans Affairs Laryngeal Cancer Study Group (1991) Induction chemotherapy plus radiation compared with surgery plus radiation in patients with advanced laryngeal cancer. N Engl J Med 324:1685–1690. doi:10.1056/NEJM199106133242402 CrossRef

66.

Pignon JP, le Maître A, Maillard E, Bourhis J, MACHNCC Group (2009) Meta-analysis of chemotherapy in head and neck cancer (MACH-NC): an update on 93 randomised trials and 17, 346 patients. Radiother Oncol 92:4–14. doi:10.1016/j.radonc.2009.04.014 CrossRefPubMed

67.

Higgins KM, Wang JR (2008) State of head and neck surgical oncology research—a review and critical appraisal of landmark studies. Head Neck 30:1636–1642. doi:10.1002/hed.20863 CrossRefPubMed

68.

Dietz A, Rudat V, Dreyhaupt J, Pritsch M, Hoppe F, Hagen R et al (2009) Induction chemotherapy with paclitaxel and cisplatin followed by radiotherapy for larynx organ preservation in advanced laryngeal and hypopharyngeal cancer offers moderate late toxicity outcome (DeLOS-I-trial). Eur Arch Otorhinolaryngol 266:1291–1300. doi:10.1007/s00405-008-0846-y CrossRefPubMed

69.

Forastiere AA, Trotti A, Pfister DG, Grandis JR (2006) Head and neck cancer: recent advances and new standards of care. J Clin Oncol 24:2603–2605. doi:10.1200/JCO.2006.07.1464 CrossRefPubMed

70.

Hanna E, Sherman A, Cash D, Adams D, Vural E, Fan CY et al (2004) Quality of life for patients following total laryngectomy vs chemoradiation for laryngeal preservation. Arch Otolaryngol Head Neck Surg 130:875–879. doi:10.1001/archotol.130.7.875 CrossRefPubMed

71.

Oates J, Clark JR, Read J, Reeves N, Gao K, O’Brien CJ (2008) Integration of prospective quality of life and nutritional assessment as routine components of multidisciplinary care of patients with head and neck cancer. ANZ J Surg 78:34–41. doi:10.1111/j.1445-2197.2007.04353.x CrossRefPubMed

72.

Hoffmann M, Görögh T, Gottschlich S, Lohrey C, Rittgen W, Ambrosch P et al (2005) Human papillomaviruses in head and neck cancer: 8 year-survival-analysis of 73 patients. Cancer Lett 218:199–206. doi:10.1016/j.canlet.2004.09.027 CrossRefPubMed

Titel: Effects of tumour stage, comorbidity and therapy on survival of laryngeal cancer patients: a systematic review and a meta-analysis
verfasst von: Elisabeth Rudolph
Gerhard Dyckhoff
Heiko Becher
Andreas Dietz
Heribert Ramroth
Publikationsdatum: 01.02.2011
Verlag: Springer-Verlag
Erschienen in: European Archives of Oto-Rhino-Laryngology / Ausgabe 2/2011
Print ISSN: 0937-4477
Elektronische ISSN: 1434-4726
DOI: https://doi.org/10.1007/s00405-010-1395-8

Neu im Fachgebiet HNO

16.04.2024 | HNO-Chirurgie | Nachrichten

Update HNO

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert – ganz bequem per eMail.

Newsletter bestellen

Live-Webinar: Aktuelle Leitlinien bei Herz-Kreislauf-Erkrankungen

Springer Medizin

Effects of tumour stage, comorbidity and therapy on survival of laryngeal cancer patients: a systematic review and a meta-analysis

Abstract

Neu im Fachgebiet HNO

HNO-Op. auch mit über 90?

Intrakapsuläre Tonsillektomie gewinnt an Boden

Bilateraler Hörsturz hat eine schlechte Prognose

„Nur wer sich gut aufgehoben fühlt, kann auch für Patientensicherheit sorgen“

Update HNO

Live-Webinar: Aktuelle Leitlinien bei Herz-Kreislauf-Erkrankungen

Springer Medizin

Abstract

Bitte loggen Sie sich ein, um Zugang zu diesem Inhalt zu erhalten

Weitere Artikel der Ausgabe 2/2011

Listening to the diagnosis: a physician’s account of spontaneous carotid artery dissection

Fasciocutaneous free flap reconstruction for squamous cell carcinoma of the hypopharynx

Surgical measurement to sphenoid sinus for the Chinese in Asia based on CT using sagittal reconstruction images

Early-onset sensorineural hearing loss in Lassa fever

Basaloid squamous cell carcinoma of the upper aerodigestive tract: a single squamous cell carcinoma subtype or two distinct entities hiding under one histologic pattern?

Photodynamic therapy of early stage oral cavity and oropharynx neoplasms: an outcome analysis of 170 patients

Neu im Fachgebiet HNO

HNO-Op. auch mit über 90?

Intrakapsuläre Tonsillektomie gewinnt an Boden

Bilateraler Hörsturz hat eine schlechte Prognose

„Nur wer sich gut aufgehoben fühlt, kann auch für Patientensicherheit sorgen“

Update HNO